- Home
- Publications
- Publication Search
- Publication Details
Title
Overview of a chemoresponse assay in ovarian cancer
Authors
Keywords
Chemoresponse assay, Chemo sensitivity and resistance assay, Ovarian cancer, Chemotherapy, Personalized medicine, Individualized therapy
Journal
Clinical & Translational Oncology
Volume 16, Issue 9, Pages 761-769
Publisher
Springer Nature
Online
2014-07-02
DOI
10.1007/s12094-014-1192-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evidence of Clinical Utility: An Unmet Need in Molecular Diagnostics for Patients with Cancer
- (2014) D. R. Parkinson et al. CLINICAL CANCER RESEARCH
- Unmet Needs in Ovarian Cancer: Dividing Histologic Subtypes to Exploit Novel Targets and Pathways
- (2013) Vijaya Galic et al. CURRENT CANCER DRUG TARGETS
- A prospective study evaluating the clinical relevance of a chemoresponse assay for treatment of patients with persistent or recurrent ovarian cancer
- (2013) Thomas Rutherford et al. GYNECOLOGIC ONCOLOGY
- A phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy
- (2013) Robert M. Wenham et al. GYNECOLOGIC ONCOLOGY
- Statistical and Practical Considerations for Clinical Evaluation of Predictive Biomarkers
- (2013) M.-Y. C. Polley et al. JNCI-Journal of the National Cancer Institute
- The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapy
- (2012) L. C. Hanker et al. ANNALS OF ONCOLOGY
- Correlation of drug-induced apoptosis assay results with oncologist treatment decisions and patient response and survival
- (2012) Linda D. Bosserman et al. CANCER
- The Microculture-Kinetic (MiCK) Assay: The Role of a Drug-Induced Apoptosis Assay in Drug Development and Clinical Care
- (2012) Linda Bosserman et al. CANCER RESEARCH
- A Rational Approach to the Management of Recurrent or Persistent Ovarian Carcinoma
- (2012) TATE THIGPEN CLINICAL OBSTETRICS AND GYNECOLOGY
- Minireview: Human Ovarian Cancer: Biology, Current Management, and Paths to Personalizing Therapy
- (2012) Ignacio Romero et al. ENDOCRINOLOGY
- Correlation of pretreatment drug induced apoptosis in ovarian cancer cells with patient survival and clinical response
- (2012) Emery Salom et al. Journal of Translational Medicine
- Correlation of the microculture-kinetic drug-induced apoptosis assay with patient outcomes in initial treatment of adult acute myelocytic leukemia
- (2012) Stephen A. Strickland et al. LEUKEMIA & LYMPHOMA
- ß3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells
- (2012) David A Tumbarello et al. Molecular Cancer
- American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Chemotherapy Sensitivity and Resistance Assays
- (2011) Harold J. Burstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase 3 Trial of Bevacizumab in Ovarian Cancer
- (2011) Timothy J. Perren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trabectedin Plus Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer
- (2010) Bradley J. Monk et al. JOURNAL OF CLINICAL ONCOLOGY
- Endometrial carcinoma in vitro chemosensitivity testing of single and combination chemotherapy regimens using the novel microculture kinetic apoptosis assay: implications for endometrial cancer treatment
- (2010) Karen S. Ballard et al. Journal of Gynecologic Oncology
- Randomized Clinical Trials With Biomarkers: Design Issues
- (2010) B. Freidlin et al. JNCI-Journal of the National Cancer Institute
- Chemosensitivity and chemoresistance testing in ovarian cancer
- (2009) Ian A Cree CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- The Scientific Foundation for Personal Genomics: Recommendations from a National Institutes of Health–Centers for Disease Control and Prevention Multidisciplinary Workshop
- (2009) Muin J Khoury et al. GENETICS IN MEDICINE
- Recommendations from the EGAPP Working Group: can tumor gene expression profiling improve outcomes in patients with breast cancer?
- (2009) GENETICS IN MEDICINE
- Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup
- (2009) Michael A. Bookman et al. JOURNAL OF CLINICAL ONCOLOGY
- Robotic Liquid Handlers and Semiautomated Cell Quantification Systems Increase Consistency and Reproducibility in High-Throughput, Cell-Based Assay
- (2009) Jamie M. Heinzman et al. Journal of the Association for Laboratory Automation.
- Nonplatinum Topotecan Combinations Versus Topotecan Alone for Recurrent Ovarian Cancer: Results of a Phase III Study of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group
- (2008) Jalid Sehouli et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now